<DOC>
	<DOC>NCT00154206</DOC>
	<brief_summary>The aim of this pilot study is to evaluate efficacy and tolerability of EC-MPS b.i.d, with Cyclosporine microemulsion and steroids in pediatric de novo renal transplant patients. Safety and doses variations are also evaluated.</brief_summary>
	<brief_title>Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Recipients of a primary renal transplantation Recipients of a renal transplantation only Recipients of a multiorgan transplantation Unable to take an oral medication Requiring an induction therapy with polyclonal, monoclonal antibodies (OKT3, ATG, ALG). Other protocoldefined inclusion / exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Enteric-coated mycophenolate sodium,</keyword>
	<keyword>de novo,</keyword>
	<keyword>renal transplantation,</keyword>
	<keyword>pediatric</keyword>
	<keyword>De novo pediatric renal transplantation</keyword>
</DOC>